Pendal Group Ltd - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 263 filers reported holding CONMED CORP in Q4 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
Pendal Group Ltd ownership history of CONMED CORP
ValueSharesWeighting
Q3 2019$1,472,537,000
+4.0%
15,315
-7.5%
0.02%
-5.0%
Q2 2019$1,416,526,000
+8.8%
16,554
+5.8%
0.02%
+11.1%
Q1 2019$1,301,933,000
+29.6%
15,6520.0%0.02%
+12.5%
Q4 2018$1,004,858,000
-13.4%
15,652
+6.9%
0.02%0.0%
Q3 2018$1,160,256,000
-41.5%
14,646
-46.0%
0.02%
-38.5%
Q2 2018$1,984,306,000
+20.5%
27,108
+4.3%
0.03%
+23.8%
Q1 2018$1,646,580,000
+26.0%
26,000
+1.4%
0.02%
+23.5%
Q4 2017$1,306,769,000
-1.2%
25,638
+1.8%
0.02%0.0%
Q3 2017$1,322,087,000
+75.0%
25,197
+69.9%
0.02%
+54.5%
Q2 2017$755,287,00014,8270.01%
Other shareholders
CONMED CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Hood River Capital Management LLC 448,126$38,346,0001.80%
HealthCor Management, L.P. 455,190$38,951,0001.51%
Champlain Investment Partners, LLC 1,452,360$124,278,0001.04%
J. Goldman & Co LP 162,771$13,928,0000.96%
Granahan Investment Management 189,925$16,252,0000.80%
PURA VIDA INVESTMENTS, LLC 50,000$4,279,0000.65%
OAK RIDGE INVESTMENTS LLC 102,797$8,797,0000.61%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 78,722$6,736,0000.54%
MOODY ALDRICH PARTNERS LLC 23,834$2,039,0000.52%
361 CAPITAL LLC 30,901$2,644,0000.47%
View complete list of CONMED CORP shareholders